ARCHIVES

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

Litton Loses To PRI On Largest Frederick Contract, Competing Against Hopkins For Science Program

August 27, 1982

FDA Policy On Support Of Medical Education Near Final Form

February 5, 1993

Von Eschenbach To Leave FDA Jan. 20, Says He Was “In Love” With The Agency.

December 19, 2008

ASCO Explores White, Minority Cancer Problem

July 13, 1990

Cooperative Groups Advised To Plan For Future Of Less Funding from NCI

June 16, 1995

Senate Committee Passes Bill To Speed FDA Approval Of Follow-On Biologics.

June 29, 2007